Survey of members of myeloma UK on biphosphonates-associated jaw osteonecrosis [4]

British Journal of Haematology

Volumn 139, Issue 4, 2007, Pages 626-628

  Barker, Kate ^a   Lowe, Derek ^a   Olujohungbe, Ade ^a   Low, Eric ^b   Rogers, Simon N ^a,c  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b MYELOMA UK   (United Kingdom)

^c EDGE HILL UNIVERSITY   (United Kingdom)

Author keywords

Bisphosphonates; Mandible; Maxilla; Myeloma; Osteonecrosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

BONE NECROSIS; DENTAL CARE; DENTAL HEALTH; HEALTH CARE PERSONNEL; HUMAN; JAW OSTEONECROSIS; LETTER; MOUTH HYGIENE; MYELOMA; PRIORITY JOURNAL; TOOTH EXTRACTION; UNITED KINGDOM;

DENTAL CARE; DIPHOSPHONATES; HUMANS; JAW DISEASES; MULTIPLE MYELOMA; OSTEONECROSIS; PATIENT EDUCATION AS TOPIC; PROFESSIONAL PRACTICE;

EID: 35748957133     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06730.x     Document Type: Letter

References (6)

1. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons 2007) American Association of Oral and Maxillofacial Surgeons Position Paper on bisphosphonate-related osteonecrosis of the jaws. Journal of Oral Maxillofacial Surgery 2007, 65, 369 376.
2. American Association of Oral and Maxillofacial Surgeons (2006) American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-related Osteonecrosis of the jaws, 25th September 2006. Rosemont, IL. WWW document. URL. http://www.aaoms.org/docs/position_papers/osteonecrosis. pdf
3. Barker, K. Rogers, S.N. (2006) Bisphosphonate-associated osteonecrosis of the jaws: a guide for the general dental practitioner. Dental Update, 33, 270 272.
4. Damato, K., Gralow, J., Hoff, A., Huryn, J., Marx, R., Ruggiero, S., Schubert, M., Toth, B. Valero, V. (2005) Novartis Pharmaceuticals Corporation. Important Drug Precaution for Dental Health Professionals with Patients Being Treated for Cancer [Letter to Dentists]. US Food and Drug Administration, Rockville, MD.
5. Marx, R.E., Sawatari, Y., Fortin, M. Broumand, V. (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. Journal of Oral and Maxillofacial Surgery, 63, 1567 1575.
6. Ruggiero, S.L., Mehrotra, B., Rosenberg, T.J. Engroff, S.L. (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. Journal of Oral and Maxillofacial Surgery, 62, 527 534.